scholarly journals Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.

1996 ◽  
Vol 81 (3) ◽  
pp. 1189-1196 ◽  
Author(s):  
M Thorner ◽  
P Rochiccioli ◽  
M Colle ◽  
R Lanes ◽  
J Grunt ◽  
...  
1990 ◽  
Vol 34 (2) ◽  
pp. 71-74 ◽  
Author(s):  
E. Arilla ◽  
J. Fragoso ◽  
R. Barria ◽  
B. Colás ◽  
S. Donnay ◽  
...  

Author(s):  
Eva Horvath ◽  
Kalman Kovacs ◽  
B. W. Scheithauer ◽  
R. V. Lloyd ◽  
H. S. Smyth

The association of a pituitary adenoma with nervous tissue consisting of neuron-like cells and neuropil is a rare abnormality. In the majority of cases, the pituitary tumor is a chromophobic adenoma, accompanied by acromegaly. Histology reveals widely variable proportions of endocrine and nervous tissue in alternating or intermingled patterns. The lesion is perceived as a composite one consisting of two histogenetically distinct parts. It has been suggested that the neuronal component, morphologically similar to secretory neurons of the hypothalamus, may initiate adenoma formation by releasing stimulatory substances. Immunoreactivity for growth hormone releasing hormone (GRH) in the neuronal component of some cases supported this view, whereas other findings such as consistent lack of growth hormone (GH) cell hyperplasia in the lesions called for alternative explanation.Fifteen tumors consisting of a pituitary adenoma and a neuronal component have been collected over a 20 yr. period. Acromegaly was present in 11 patients, was equivocal in one, and absent in 3.


Sign in / Sign up

Export Citation Format

Share Document